Role Of Sensitivity to neuroEndocrine Systems in Social Decisions

NCT06018727 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Changed study design and it is no longer a clinical trial.

Conditions

Borderline Personality Disorder

Interventions

DRUG: Hydrocortisone
DIETARY_SUPPLEMENT: Yohimbine
DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill